CClinicalTrials.gg
CompletedNCT00585728Updated Dec 13, 2019

CT Virtual Proctoscopy for Staging and Volume Assessment for Rectal Cancer

An interventional study of CT Virtual Proctoscopy (CTVP) in Rectal Cancer, sponsored by University of Wisconsin, Madison. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-12-13.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to see how CT virtual proctoscopy compares to an ultrasound exam of the rectal area in determining the stage of rectal cancer for people recently diagnosed with rectal cancer. This study will also compare tumor volume before and after neoadjuvant therapy using CT virtual proctoscopy, with the ultrasound exam as a comparison. Neoadjuvant therapy consists of chemotherapy and radiation therapy. Neoadjuvant chemoradiation therapy is done before surgery to reduce the size of tumors.

02

Conditions studied

  • Rectal Cancer

Browse trials for

03

In context

Rectal Neoplasms

1,762 studies on the registry are indexed under Rectal Neoplasms; 518 are open to participants now.

This study's enrollment of 20 is below the median of 65 across 1,298 interventional studies indexed under Rectal Neoplasms.

Browse Rectal Neoplasms studies →

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,161 studies on the registry; 182 are open to participants now.

Of its 151 completed or terminated interventional studies of FDA-regulated products, 114 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients who have been diagnosed with adenocarcinoma of the rectum, who have not started their neoadjuvant treatment yet.

Exclusion criteria

Exclusion Criteria:

  • Patients who have started their neoadjuvant therapy already
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Other
    1

    CT virtual proctoscopy

    Procedure: CT Virtual Proctoscopy (CTVP)

Interventions

  • ProcedureCT Virtual Proctoscopy (CTVP)

    CTVP done prior to initiation of therapy and a couple of weeks before patient has surgery.

06

What researchers measure

Primary outcomes

  1. The utility of CT virtual proctoscopy (CTVP) for evaluation of rectal cancer.

    Time frame: 3 months

07

Study locations

1 site
  • University of Wisconsin Hospital & Clinics
    Madison, Wisconsin 53792, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 13, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00585728
Lead sponsor
University of Wisconsin, Madison
Responsible party
Sponsor
First posted
Jan 3, 2008
Start date
Sep 2007
Primary completion
Aug 2011
Completion
Aug 2011
Last update
Dec 13, 2019

Study contacts

Charles P Heise, M.D.
principal investigator · UW Hospital & Clinics, Department of Surgery

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion